Seoul, South Korea

Hyeran Yang

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Idience Co., Ltd., Il Dong Pharmaceutical Co., Ltd.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyeran Yang. Retrieved from https://idiyas.com/inventor/hyeran-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hyeran Yang

Introduction

Hyeran Yang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of three patents. His work focuses on the development of novel compounds and methods that enhance the efficacy and purity of pharmaceutical products.

Latest Patents

Hyeran Yang's latest patents include a process for preparing a phthalazinone derivative and intermediates thereof. This application provides a method for synthesizing 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one, along with its pharmaceutically acceptable salts. The methods described result in high purity and yield, making them valuable for pharmaceutical applications. Another significant patent involves the crystalline forms of the phthalazinone compound, specifically 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one hydrochloride. This patent outlines methods for preparing these crystalline forms and the pharmaceutical compositions that incorporate them.

Career Highlights

Throughout his career, Hyeran Yang has worked with prominent companies in the pharmaceutical industry, including Idience Co., Ltd. and Il Dong Pharmaceutical Co., Ltd.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…